<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmchealthservres&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Health Services Research - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmchealthservres/</link>
        <description>The latest research articles published by BMC Health Services Research</description>
        <dc:date>2009-07-10T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6963/9/115" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6963/9/114" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6963/9/113" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6963/9/112" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6963/9/111" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6963/9/110" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6963/9/109" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6963/9/108" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6963/9/107" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6963/9/106" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1472-6963/9/115">
        <title>Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers</title>
        <description>Background:
Tissue engineering is an emerging field. Novel bioengineered skin substitutes and genetically derived growth factors offer innovative approaches to reduce the burden of diabetic foot and venous leg ulcers for both patients and health care systems. However, they frequently are very costly. Based on a systematic review of the literature, this study assesses the cost-effectiveness of these growth factors and tissue-engineered artificial skin for treating chronic wounds.
Methods:
On the basis of an extensive explorative search, an appropriate algorithm for a systematic database search was developed. The following databases were searched: BIOSIS Previews, CRD databases, Cochrane Library, EconLit, Embase, Medline, and Web of Science. Only completed and published trial- or model-based studies which contained a full economic evaluation of growth factors and bioengineered skin substitutes for the treatment of chronic wounds were included. Two reviewers independently undertook the assessment of study quality. The relevant studies were assessed by a modified version of the Consensus on Health Economic Criteria (CHEC) list and a published checklist for evaluating model-based economic evaluations.
Results:
Eleven health economic evaluations were included. Three biotechnology products were identified for which topical growth factors or bioengineered skin substitutes for the treatment of chronic leg ulceration were economically assessed: (1) Apligraf(R), a bilayered living human skin equivalent indicated for the treatment of diabetic foot and venous leg ulcers (five studies); (2) Dermagraft(R), a human fibroblast-derived dermal substitute, which is indicated only for use in the treatment of full-thickness diabetic foot ulcers (one study); (3) REGRANEX(R) Gel, a human platelet-derived growth factor for the treatment of deep neuropathic diabetic foot ulcers (five studies). The studies considered in this review were of varying and partly low methodological quality. They calculated that due to shorter treatment periods, fewer complications and fewer inpatient episodes the initial cost of the novel biotechnology products may be offset, making the treatment cost-effective or even cost-saving. The results of most studies were sensitive to initial costs of the products and the evidence of effectiveness.
Conclusions:
The study results suggest that some growth factors and tissue-engineered artificial skin products feature favourable cost-effectiveness ratios in selected patient groups with chronic wounds. Despite the limitations of the studies considered, it is evident that health care providers and coverage decision makers should take not only the high cost of the biotechnology product but the total cost of care into account when deciding about the appropriate allocation of their financial resources. However, not only the cost-effectiveness but first of all the effectiveness of these novel biotechnology products deserve further research.</description>
        <link>http://www.biomedcentral.com/1472-6963/9/115</link>
                <dc:creator>Astrid Langer</dc:creator>
                <dc:creator>Wolf Rogowski</dc:creator>
                <dc:source>BMC Health Services Research 2009, 9:115</dc:source>
        <dc:date>2009-07-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6963-9-115</dc:identifier>
        <prism:publicationName>BMC Health Services Research</prism:publicationName>
        <prism:issn>1472-6963</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>115</prism:startingPage>
        <prism:publicationDate>2009-07-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6963/9/114">
        <title>Screening and brief interventions for hazardous alcohol use in accident and emergency departments: a randomised controlled trial protocol. </title>
        <description>Background:
There is a wealth of evidence regarding the detrimental impact of excessive alcohol consumption on the physical, psychological and social health of the population. There also exists a substantial evidence base for the efficacy of brief interventions aimed at reducing alcohol consumption across a range of healthcare settings. Primary research conducted in emergency departments has reinforced the current evidence regarding the potential effectiveness and cost-effectiveness. Within this body of evidence there is marked variation in the intensity of brief intervention delivered, from very minimal interventions to more intensive behavioural or lifestyle counselling approaches. Further the majority of primary research has been conducted in single centre and there is little evidence of the wider issues of generalisability and implementation of brief interventions across emergency departments.Methods/designThe study design is a prospective pragmatic factorial cluster randomised controlled trial. Individual Emergency Departments (ED) (n=9) are randomised with equal probability to a combination of screening tool (M-SASQ vs FAST vs SIPS-PAT) and an intervention (Minimal intervention vs Brief advice vs Brief lifestyle counselling). The primary hypothesis is that brief lifestyle counselling delivered by an Alcohol Health Worker (AHW) is more effective than Brief Advice or a minimal intervention delivered by ED staff. Secondary hypotheses address whether short screening instruments are more acceptable and as efficient as longer screening instruments and the cost-effectiveness of screening and brief interventions in ED. Individual participants will be followed up at 6 and 12 months after consent. The primary outcome measure is performance using a gold-standard screening test (AUDIT). Secondary outcomes include; quantity and frequency of alcohol consumed, alcohol-related problems, motivation to change, health related quality of life and service utilisation.DiscussionThis paper presents a protocol for a large multi-centre pragmatic factorial cluster randomised trial to evaluate the effectiveness and cost-effectiveness of screening and brief interventions for hazardous alcohol users attending emergency departments.</description>
        <link>http://www.biomedcentral.com/1472-6963/9/114</link>
                <dc:creator>Simon Coulton</dc:creator>
                <dc:creator>Katherine Perryman</dc:creator>
                <dc:creator>Martin Bland</dc:creator>
                <dc:creator>Paul Cassidy</dc:creator>
                <dc:creator>Mike Crawford</dc:creator>
                <dc:creator>Paolo Deluca</dc:creator>
                <dc:creator>Colin Drummond</dc:creator>
                <dc:creator>Eilish Gilvarry</dc:creator>
                <dc:creator>Christine Godfrey</dc:creator>
                <dc:creator>Nick Heather</dc:creator>
                <dc:creator>Eileen Kaner</dc:creator>
                <dc:creator>Judy Myles</dc:creator>
                <dc:creator>Dorothy Newbury-Birch</dc:creator>
                <dc:creator>Adenekan Oyefeso</dc:creator>
                <dc:creator>Steve Parrott</dc:creator>
                <dc:creator>Tom Phillips</dc:creator>
                <dc:creator>Don Shenker</dc:creator>
                <dc:creator>Jonathon Shepherd</dc:creator>
                <dc:source>BMC Health Services Research 2009, 9:114</dc:source>
        <dc:date>2009-07-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6963-9-114</dc:identifier>
        <prism:publicationName>BMC Health Services Research</prism:publicationName>
        <prism:issn>1472-6963</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>114</prism:startingPage>
        <prism:publicationDate>2009-07-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6963/9/113">
        <title>Development of a nursing intervention to facilitate optimal antiretroviral-treatment taking among people living with HIV</title>
        <description>Background:
Failure by a large portion of PLHIV to take optimally ARV treatment can have serious repercussions on their health. The absence of a systematic treatment-taking promotion program in Quebec prompted stakeholders to develop jointly a theory- and evidence-based nursing intervention to this end. This article describes the results of a collective effort by researchers, clinicians and PLHIV to share their knowledge and create an appropriate intervention.
Methods:
Intervention mapping was used as the framework for developing the intervention. First, the target population and environmental conditions were analyzed and a literature review conducted to identify predictors of optimal treatment taking. The predictors to emerge were self-efficacy and attitudes. Performance objectives were subsequently defined and crossed-referenced with the predictors to develop a matrix of change objectives. Then, theories of self-efficacy and persuasion (the predictors to emerge from step 1), together with practical strategies derived from these theories, were used to design the intervention. Finally, the sequence and content of the intervention activities were defined and organized, and the documentary material designed.
Results:
The intervention involves an intensive, personalized follow-up over four direct-contact sessions, each lasting 45-75 minutes. Individuals are engaged in a learning process that leads to the development of skills to motivate themselves to follow the therapeutic plan properly, to overcome situations that make taking the antiretroviral medication difficult, to cope with side-effects, to relate to people in their social circle, and to deal with health professionals.
Conclusion:
The intervention was validated by various health professionals and pre-tested with four PLHIV. Preliminary results support the suitability and viability of the intervention. A randomized trial is currently underway to verify the effectiveness of the intervention in promoting optimal antiretroviral treatment taking.</description>
        <link>http://www.biomedcentral.com/1472-6963/9/113</link>
                <dc:creator>Pilar Ramirez-Garcia</dc:creator>
                <dc:creator>Jose Cote</dc:creator>
                <dc:source>BMC Health Services Research 2009, 9:113</dc:source>
        <dc:date>2009-07-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6963-9-113</dc:identifier>
        <prism:publicationName>BMC Health Services Research</prism:publicationName>
        <prism:issn>1472-6963</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>113</prism:startingPage>
        <prism:publicationDate>2009-07-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6963/9/112">
        <title>Detection of pulmonary tuberculosis among patients with cough attending outpatient departments in Dar Es Salaam, Tanzania: does duration of cough matter?</title>
        <description>Background:
According to WHO estimates, tuberculosis case detection rate in Tanzania is less than 50% and this poses a major challenge to control tuberculosis in the country. Currently, one of the defining criteria for suspecting tuberculosis is cough for two weeks or more. We wanted to find out whether the prevalence of tuberculosis was different in patients who reported cough for two weeks or more, compared to patients with cough for less than two weeks.
Methods:
We conducted a cross sectional hospital based study in six health facilities in Dar es Salaam, between September and October 2007. All patients aged five years and above with cough were screened for pulmonary tuberculosis (PTB) by smear microscopy. Patients were divided into two groups, those who coughed for less than two weeks (&lt;2 wks) and those who coughed for two weeks or more ([greater than or equal to]2 wks).
Results:
A total of 65,530 patients attended outpatients department (OPD). Out of these, 2274 (3.5%) patients reported cough. Among patients who reported cough, 2214 (97.4%) remembered their cough duration. One thousand nine hundred and seventy three patients (89.1%) coughed for [greater than or equal to]2 wks as compared to 241 (10.9%) patients who coughed for &lt;2 wks. Of those who coughed for two weeks or more, 250 (12.7%) had smear positive PTB, and of those who had coughed for less than two weeks, 21 (8.7%) had smear positive PTB. There was no statistically significant difference in prevalence of smear positive tuberculosis among the two groups (Pearson Chi-Square 3.2; p=0.074).
Conclusions:
Detection of smear positive PTB among patients who coughed for less than two weeks was as high as for those who coughed for two weeks or more.</description>
        <link>http://www.biomedcentral.com/1472-6963/9/112</link>
                <dc:creator>Esther Ngadaya</dc:creator>
                <dc:creator>Godfrey Mfinanga</dc:creator>
                <dc:creator>Eliud Wandwalo</dc:creator>
                <dc:creator>Odd Morkve</dc:creator>
                <dc:source>BMC Health Services Research 2009, 9:112</dc:source>
        <dc:date>2009-07-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6963-9-112</dc:identifier>
        <prism:publicationName>BMC Health Services Research</prism:publicationName>
        <prism:issn>1472-6963</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>112</prism:startingPage>
        <prism:publicationDate>2009-07-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6963/9/111">
        <title>A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients</title>
        <description>Background:
Diabetic neuropathy (DN) is a common complication of diabetes that has significant economic burden, especially for patients with comorbid depression or anxiety. This study examines and quantifies factors associated with healthcare costs among patients diagnosed with diabetic neuropathy (DN) with or without a comorbid diagnosis of depression or anxiety (DA) using retrospective administrative claims data. No study has examined the differences in economic outcomes depending on the presence of comorbid DA disorders.
Methods:
Over-age-18 individuals with 1+ diagnosis of DN in 2005 were selected. The first observed DN claim was considered the &quot;index date.&quot; All individuals had a 12-month pre-index and follow-up period. For both under-age-65 commercially insured and over-age-65 individuals with employer-sponsored Medicare supplemental insurance, we constructed 2 subgroups for individuals with DA (DN-DA) or without (DN-only). Patients&apos; clinical characteristics over pre-index period were compared. Multivariate regressions were performed to assess whether DN-DA patients had higher utilization of healthcare resources and costs than DN-only patients, controlling for demographic and clinical characteristics.
Results:
We identified 16,831 DN-only and 1,699 DN-DA patients in the Medicare supplemental cohort, as well as 17,205 and 3,105 in the commercially insured. DN-DA patients had higher prevalence of diabetes-related comorbidities for cardiovascular disease, cerebrovascular/peripheral vascular disease, nephropathy, obesity, and hypoglycemic events than DN-only patients (all p&lt;0.05). Controlling for differences in demographic and clinical characteristics, DN-DA patients had $9,235 (p&lt;0.05) higher total healthcare costs than patients with DN-only among those with Medicare supplemental coverage ($26,718 vs. $17,483), and $10,389 (p&lt;0.05) more total costs among commercially insured ($29,775 vs. $19,386). Factors associated with increased costs included insurance type, geographical region, diabetes-related comorbidities, and insulin therapy.
Conclusion:
These findings indicate that the healthcare costs were significantly higher for DN patients with depression or anxiety relative to those without such comorbid disorders.</description>
        <link>http://www.biomedcentral.com/1472-6963/9/111</link>
                <dc:creator>Luke Boulanger</dc:creator>
                <dc:creator>Yang Zhao</dc:creator>
                <dc:creator>Yanjun Bao</dc:creator>
                <dc:creator>Mason Russell</dc:creator>
                <dc:source>BMC Health Services Research 2009, 9:111</dc:source>
        <dc:date>2009-06-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6963-9-111</dc:identifier>
        <prism:publicationName>BMC Health Services Research</prism:publicationName>
        <prism:issn>1472-6963</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>111</prism:startingPage>
        <prism:publicationDate>2009-06-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6963/9/110">
        <title>Participant observation of time allocation, direct patient contact, and simultaneous activities in hospital physicians</title>
        <description>Background:
Hospital physicians&apos; time is a critical resource in medical care. Two aspects are of interest. First, the time spent in direct patient contact &#8211; a key principle of effective medical care. Second, simultaneous task performance (&apos;multitasking&apos;) which may contribute to medical error, impaired safety behaviour, and stress. There is a call for instruments to assess these aspects. A preliminary study to gain insight into activity patterns, time allocation and simultaneous activities of hospital physicians was carried out. Therefore an observation instrument for time-motion-studies in hospital settings was developed and tested.
Methods:
35 participant observations of internists and surgeons of a German municipal 300-bed hospital were conducted. Complete day shifts of hospital physicians on wards, emergency ward, intensive care unit, and operating room were continuously observed. Assessed variables of interest were time allocation, share of direct patient contact, and simultaneous activities. Inter-rater agreement of Kappa = .71 points to good reliability of the instrument.
Results:
Hospital physicians spent 25.5% of their time at work in direct contact with patients. Most time was allocated to documentation and conversation with colleagues and nursing staff. Physicians performed parallel simultaneous activities for 17&#8211;20% of their work time. Communication with patients, documentation, and conversation with colleagues and nursing staff were the most frequently observed simultaneous activities. Applying logit-linear analyses, specific primary activities increase the probability of particular simultaneous activities.
Conclusion:
Patient-related working time in hospitals is limited. The potential detrimental effects of frequently observed simultaneous activities on performance outcomes need further consideration.</description>
        <link>http://www.biomedcentral.com/1472-6963/9/110</link>
                <dc:creator>Matthias Weigl</dc:creator>
                <dc:creator>Andreas Muller</dc:creator>
                <dc:creator>Andrea Zupanc</dc:creator>
                <dc:creator>Peter Angerer</dc:creator>
                <dc:source>BMC Health Services Research 2009, 9:110</dc:source>
        <dc:date>2009-06-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6963-9-110</dc:identifier>
        <prism:publicationName>BMC Health Services Research</prism:publicationName>
        <prism:issn>1472-6963</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>110</prism:startingPage>
        <prism:publicationDate>2009-06-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6963/9/109">
        <title>The ACTIVE cognitive training trial and predicted medical expenditures </title>
        <description>Background:
Health care expenditures for older adults are disproportionately high and increasing at both the individual and population levels.  We evaluated the effects of the three cognitive training interventions (memory, reasoning, or speed of processing) in the ACTIVE study on changes in predicted medical care expenditures.MethodACTIVE was a multisite randomized controlled trial of older adults (&gt; 65).  Five-year follow-up data were available for 1,804 of the 2,802 participants.  Propensity score weighting was used to adjust for potential attrition bias.  Changes in predicted annual medical expenditures were calculated at the first and fifth annual follow-up assessments using a new method for translating functional status scores.  Multiple linear regression methods were used in this cost-offset analysis.
Results:
At one and five years post-training, annual predicted expenditures declined by $223 (p = .024) and $128 (p = .309), respectively, in the speed of processing treatment group, but there were no statistically significant changes in the memory or reasoning treatment groups compared to the no-contact control group at either period.  Statistical adjustment for age, race, education, MMSE scores, ADL and IADL performance scores, EPT scores, chronic condition counts, and the SF-36 PCS and MCS scores at baseline did not alter the one-year ($244; p = .012) or five-year ($143; p = .250) expenditure declines in the speed of processing treatment group.
Conclusions:
The speed of processing intervention significantly reduced subsequent annual predicted medical care expenditures at the one-year post-baseline comparison, but annual savings were no longer statistically significant at the five-year post-baseline comparison.</description>
        <link>http://www.biomedcentral.com/1472-6963/9/109</link>
                <dc:creator>Fredric Wolinsky</dc:creator>
                <dc:creator>Henry Mahncke</dc:creator>
                <dc:creator>Mark Kosinski</dc:creator>
                <dc:creator>Frederick Unverzagt</dc:creator>
                <dc:creator>David Smith</dc:creator>
                <dc:creator>Richard Jones</dc:creator>
                <dc:creator>Anne Stoddard</dc:creator>
                <dc:creator>Sharon Tennstedt</dc:creator>
                <dc:source>BMC Health Services Research 2009, 9:109</dc:source>
        <dc:date>2009-06-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6963-9-109</dc:identifier>
        <prism:publicationName>BMC Health Services Research</prism:publicationName>
        <prism:issn>1472-6963</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>109</prism:startingPage>
        <prism:publicationDate>2009-06-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6963/9/108">
        <title>The UK Quality and Outcomes Framework pay-for-performance scheme and spirometry: rewarding quality or just quantity? A cross-sectional study in Rotherham, UK.</title>
        <description>Background:
Accurate spirometry is important in the management of COPD. The UK Quality and Outcomes Framework pay-for-performance scheme for general practitioners includes spirometry related indicators within its COPD domain. It is not known whether high achievement against QOF spirometry indicators is associated with spirometry to BTS standards.
Methods:
Data were obtained from the records of 3,217 patients randomly sampled from 5,649 patients with COPD in 38 general practices in Rotherham, UK. Severity of airflow obstruction was categorised by FEV1 (% predicted) according to NICE guidelines. This was compared with clinician recorded COPD severity. The proportion of patients whose spirometry met BTS standards was calculated in each practice using a random sub-sample of 761 patients. The Spearman rank correlation between practice level QOF spirometry achievement and performance against BTS spirometry standards was calculated.
Results:
Spirometry as assessed by clinical records was to BTS standards in 31% of cases (range at practice level 0% to 74%). The categorisation of airflow obstruction according to the most recent spirometry results did not agree well with the clinical categorisation of COPD recorded in the notes (Cohen&apos;s kappa = 0.34, 0.30 &#8211; 0.38). 12% of patients on COPD registers had FEV1 (% predicted) results recorded that did not support the diagnosis of COPD. There was no association between quality, as measured by adherence to BTS spirometry standards, and either QOF COPD9 achievement (Spearman&apos;s rho = -0.11), or QOF COPD10 achievement (rho = 0.01).
Conclusion:
The UK Quality and Outcomes Framework currently assesses the quantity, but not the quality of spirometry.</description>
        <link>http://www.biomedcentral.com/1472-6963/9/108</link>
                <dc:creator>Mark Strong</dc:creator>
                <dc:creator>Gail South</dc:creator>
                <dc:creator>Robin Carlisle</dc:creator>
                <dc:source>BMC Health Services Research 2009, 9:108</dc:source>
        <dc:date>2009-06-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6963-9-108</dc:identifier>
        <prism:publicationName>BMC Health Services Research</prism:publicationName>
        <prism:issn>1472-6963</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>108</prism:startingPage>
        <prism:publicationDate>2009-06-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6963/9/107">
        <title>Health services research doctoral core competencies</title>
        <description>This manuscript presents an initial description of doctoral level core competencies for health services research (HSR). The competencies were developed by a review of the literature, text analysis of institutional accreditation self-studies submitted to the Council on Education for Public Health, and a consensus conference of HSR educators from US educational institutions. The competencies are described in broad terms which reflect the unique expertise, interests, and preferred learning methods of academic HSR programs. This initial set of core competencies is published to generate further dialogue within and outside of the US about the most important learning objectives and methods for HSR training and to clarify the unique skills of HSR training program graduates.</description>
        <link>http://www.biomedcentral.com/1472-6963/9/107</link>
                <dc:creator>Christopher Forrest</dc:creator>
                <dc:creator>Diane Martin</dc:creator>
                <dc:creator>Erin Holve</dc:creator>
                <dc:creator>Anne Millman</dc:creator>
                <dc:source>BMC Health Services Research 2009, 9:107</dc:source>
        <dc:date>2009-06-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6963-9-107</dc:identifier>
        <prism:publicationName>BMC Health Services Research</prism:publicationName>
        <prism:issn>1472-6963</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>107</prism:startingPage>
        <prism:publicationDate>2009-06-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6963/9/106">
        <title>Physicians&apos; attitudes about obesity and their relation to competency and patient weight loss:  A cross-sectional survey</title>
        <description>Background:
Physicians frequently report negative attitudes about obesity which is thought to affect patient care. However, little is known about how attitudes toward treating obese patients are formed. We conducted a cross-sectional survey of physicians in order to better characterize their attitudes and explore the relationships among attitudes, perceived competency in obesity care, including report of weight loss in patients, and other key physician, training, and practice characteristics.
Methods:
We surveyed all 399 physicians from internal medicine, pediatrics, and psychiatry specialties at one institution regarding obesity care attitudes, competency, including physician report of percent of their patients who lose weight. We performed a factor analysis on the attitude items and used hierarchical regression analysis to explore the degree to which competency, reported weight loss, physician, training and practice characteristics explained the variance in each attitude factor.
Results:
The overall response rate was 63%. More than 40% of physicians had a negative reaction towards obese patients, 56% felt qualified to treat obesity, and 46% felt successful in this realm. The factor analysis revealed 4 factors&#8211;Physician Discomfort/Bias, Physician Success/Self Efficacy, Positive Outcome Expectancy, and Negative Outcome Expectancy. Competency and reported percent of patients who lose weight were most strongly associated with the Physician Success/Self Efficacy attitude factor. Greater skill in patient assessment was associated with less Physician Discomfort/Bias. Training characteristics were associated with outcome expectancies with newer physicians reporting more positive treatment expectancies. Pediatric faculty was more positive and psychiatry faculty less negative in their treatment expectancies than internal medicine faculty.
Conclusion:
Physician attitudes towards obesity are associated with competency, specialty, and years since postgraduate training. Further study is necessary to determine the direction of influence and to explore the impact of these attitudes on patient care.</description>
        <link>http://www.biomedcentral.com/1472-6963/9/106</link>
                <dc:creator>Melanie Jay</dc:creator>
                <dc:creator>Adina Kalet</dc:creator>
                <dc:creator>Tavinder Ark</dc:creator>
                <dc:creator>Michelle McMacken</dc:creator>
                <dc:creator>Mary Jo Messito</dc:creator>
                <dc:creator>Regina Richter</dc:creator>
                <dc:creator>Sheira Schlair</dc:creator>
                <dc:creator>Scott Sherman</dc:creator>
                <dc:creator>Sondra Zabar</dc:creator>
                <dc:creator>Colleen Gillespie</dc:creator>
                <dc:source>BMC Health Services Research 2009, 9:106</dc:source>
        <dc:date>2009-06-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6963-9-106</dc:identifier>
        <prism:publicationName>BMC Health Services Research</prism:publicationName>
        <prism:issn>1472-6963</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>106</prism:startingPage>
        <prism:publicationDate>2009-06-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
